Results 201 to 210 of about 901,815 (336)
Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144]. [PDF]
Clin Immunol, 2022 Montes M, Zhang X, Berthelot L, Laplaud DA, Brouard S, Jin J, Rogan S, Armao D, Jewells V, Soulillou JP, Markovic-Plese S. +10 moreeuropepmc +1 more sourcePoster Session 3: Adaptive and Innate Immunology; Alcohol: Clinical and Experimental [PDF]
, 2015 Ana Silvera, Concepcion San- Chez, Miguel Escobedo, Gabriela Alarcon-Galvan, Paula Cordero, Homero Zapata, Edelmiro Perez-Rodriguez, Asdrubal Guevara, Marco Hernan- Dez-Guedea, Linda Muoz, Alejandro Torres Hernandez, Stephanie Greco, S Rokosh, Lena Tomkoetter, Donnele Daley, Muhammad Salyana, Alek- Sandr Kalabin, Gregor Werba, George Miller, Surgery, Ronald Busuttil -Grant, Shi Yue, Changyong Li, Xingliang Zhou, Qilong Ying, Jerzy Kupiec-Weglinski, Bibo Ke, Xinshou Ouyang, Sheng-Na Han, Irma Garcia-Martinez, Luke Cai, Richard Flavell, Wajahat Mehal, Jijing Tian, Guo-Xiang Yang, Fu-Tong Liu, M Eric Gersh- Win, Natalie Torok, Joy Jiang, Ucdmc, Christian Strassburg, Novartis, Merz, Falk, Benjamin Krmer, Beatriz Turrin, Claudia Finnemann, Philipp Lutz, Andreas Glssner, Franziska Wolter, Pavlos Kokordelis, Dominik Kaczmarek, Felix Goeser, Ulrich Spengler, Jacob Nattermann, Pierre-Emmanuel Rautou, Dominique Valla, Francois Durand, Marc Pineton De Chambrun, Emmanuel Weiss, Magali Fasseu, Mikhael Giabicani, Rakhi Maiwall, Didier Lebrec, Sophie Lotersztajn, Richard Moreau, Erin Doyle, Adeeb Rahman, Arielle Klepper, Sang Kim, Brandy Haydel, Sander Florman, M Fiel, Thomas Schiano, Andrea Branch, Wagdi Almishri, Julie Deans, Mark Swain, Medicine, Pedro Melgar-Lesmes, Mercedes Balcells, Elazer Edelman, Liying Yao, Masanori Abe, Teruki Miyake, Yoshiko Nakamura, Yusuke Imai, Yohei Koizumi, Takao Watanabe, Osamu Yoshida, Masashi Hirooka, Yoshio Tokumoto, Bunzo Matsuura, Yoichi Hiasa, Craig Mcclain, Cuiqing Zhao, Liming Liu, Ying Yang, Wenke Feng, Mauricio Garcia-Saenz De Sicilia +99 moreopenalex +1 more sourceImprovements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial
Arthritis Care &Research, EarlyView.Objective
Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls +16 morewiley +1 more sourceBiologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactions. [PDF]
Allergol SelectJappe U, Bergmann KC, Brinkmann F, Faihs V, Gülsen A, Klimek L, Renz H, Seurig S, Taube C, Traidl S, Treudler R, Wagenmann M, Werfel T, Worm M, Zuberbier T. +14 moreeuropepmc +1 more sourceMonocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease
Arthritis Care &Research, EarlyView.Objective
A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.Cristina M. Padilla, Robert Lafyatis, Kevin F. Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J. Kass +13 morewiley +1 more sourceManaging Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC). [PDF]
CellsCaminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano LF, Caruso C, Cosmi L, D'Amore S, Del Giacco S, Detoraki A, Di Gioacchino M, Matucci A, Mormile I, Granata F, Guarnieri G, Krampera M, Maule M, Nettis E, Nicola S, Noviello S, Pane F, Papayannidis C, Parronchi P, Pelaia G, Ridolo E, Rossi FW, Senna G, Triggiani M, Vacca A, Vivarelli E, Vultaggio A, de Paulis A. +31 moreeuropepmc +1 more sourceHeterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes
Arthritis Care &Research, EarlyView.Objective
We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods
We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls +9 morewiley +1 more source
